Crossmark

Oral propranolol and intravitreal ranibizumab for refractory serous macular detachment secondary to retinal capillary hemangioblastoma

Crossref DOI link: https://doi.org/10.1016/j.oftale.2015.08.003

Published Print: 2015-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Hernández-Martínez, P.

Gallego-Pinazo, R.

Dolz-Marco, R.

Arevalo, J.F.

Díaz-Llopis, M.

Cisneros Lanuza, A.
License Information

Text and Data Mining valid from 2015-08-01
More Information

This article is maintained by: Elsevier

Article Title: Oral propranolol and intravitreal ranibizumab for refractory serous macular detachment secondary to retinal capillary hemangioblastoma

Journal Title: Archivos de la Sociedad Española de Oftalmología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.oftale.2015.08.003

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.oftal.2014.01.007

Content Type: simple-article

Copyright: Copyright © 2013 Sociedad Española de Oftalmología. Published by Elsevier España, S.L. All rights reserved.